Melioidosis case series
Clinical Infection in Practice · 2019
DOI: 10.1016/j.clinpr.2019.100006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infection in Practice, 2019. Verfasst von B. Merrick und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Melioidosis is a potentially fatal infection caused by Burkholderia pseudomallei , a bacterium endemic to certain tropical and subtropical world regions. It most frequently enters the body through small abrasions on the feet or lower limbs when individuals walk barefoot, or in open footwear, through contaminated wet or muddy environments. We report on three female cases successfully treated for melioidosis within the Newcastle upon Tyne NHS Hospitals over a 12-month period; a 52-year-old with a mediastinal abscess, a 38-year-old with an intra-cerebral abscess, and a 69-year-old with pneumonia and bacteraemia. Two patients were diabetic, the latter with established microvascular complications, but the third patient had no immunosuppressive risk factor identified. All had recently travelled to Thailand, although one remained solely within the confines of her holiday resort and another did not leave the city of Pattaya. Clinicians must remain vigilant to the potential for imported cases of melioidosis into the UK in travellers returning from endemic areas, such as Southeast Asia.
Zitieren
APA
Merrick, B., Jones, T., Ong, E., Price, D., & Schwab, U. (2019). Melioidosis case series. Clinical Infection in Practice. https://doi.org/10.1016/j.clinpr.2019.100006
Vancouver
Merrick B, Jones T, Ong E, Price D, Schwab U. Melioidosis case series. Clinical Infection in Practice. 2019. doi:10.1016/j.clinpr.2019.100006
BibTeX
@article{Merrick2019,
author = {Merrick, B. and Jones, T. and Ong, E. and Price, D.A. and Schwab, U.},
title = {Melioidosis case series},
journal = {Clinical Infection in Practice},
year = {2019},
doi = {10.1016/j.clinpr.2019.100006}
}
EUVIMED